SCHEMBL16015291

SCHEMBL16015291

CNC(=O)C1(O)CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
CYP3A4 P08684 2/20 0.41
HDAC4 P56524 3/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
TSHR P16473 1/20 0.31
BLM P54132 1/20 0.31
CACNA2D1 P54289 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
SLC6A3 Q01959 1/20 0.30
CETP P11597 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13451458 0.87
SCHEMBL8002686 0.75 CETP (0.44) SMN1; SMN2CYP3A4ALDH1A1LMNACETP
SCHEMBL3903447 0.75 DGAT1 (0.41) SMN1; SMN2HDAC4KDM4EALDH1A1USP2
SCHEMBL15199091 0.75 CYP2C9 (0.34) LMNACYP1A2
SCHEMBL15199090 0.75 CYP2C9 (0.34) LMNACYP1A2
SCHEMBL30936120 0.74 KDM4E (0.32) KDM4EKMT2A
Hydrochloric Acid SCHEMBL27934607 0.73 CETP (0.43) SMN1; SMN2CYP3A4ALDH1A1LMNACETP
SCHEMBL19429478 0.73 SMN1; SMN2 (0.40) SMN1; SMN2CYP3A4ALDH1A1NPSR1USP2
SCHEMBL4133242 0.73 CYP3A4 (0.40) SMN1; SMN2CYP3A4KDM4EALDH1A1NPSR1
SCHEMBL7522834 0.73 CYP3A4 (0.40) SMN1; SMN2CYP3A4KDM4EALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 CN disclosed
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 EP disclosed
US-9345708-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-05-24 US disclosed
US-8829007-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-09 US disclosed